[1]阮梦瑶,赵国安.纤维蛋白原与心血管疾病的相关性研究进展[J].新乡医学院学报,2020,37(5):494-497.[doi:10.7683/xxyxyxb.2020.05.022]
点击复制

纤维蛋白原与心血管疾病的相关性研究进展
分享到：

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
37
期数:
2020年5
页码:
494-497
栏目:
综述
出版日期:
2020-05-05

文章信息/Info

作者:
阮梦瑶1; 2; 赵国安1; 2
（1.新乡医学院第一附属医院心脏中心，河南　卫辉　453100；2.河南省心血管损伤与修复国际联合实验室，河南　卫辉　453100）
关键词:
纤维蛋白原; 凝血因子; 促炎因子; 心血管疾病
分类号:
R54
DOI:
10.7683/xxyxyxb.2020.05.022
文献标志码:
A
摘要:
心血管疾病已成为世界性公共卫生问题，严重影响人类生命健康和生活质量，如何简易高效评估心血管疾病的预后尤为重要。纤维蛋白原（Fib）是由肝脏合成、分泌的具有凝血功能的糖蛋白，大量基础和临床研究结果显示血浆Fib水平可作为评估心血管事件的生物标志物，对于诊断冠状动脉粥样硬化性心脏病、心房颤动、心力衰竭、心源性猝死等心血管疾病以及评估其预后具有重要意义。本文就Fib与心血管疾病的相关性研究进展进行综述。

参考文献/References:

［1］　 LIU S L,WU N Q,SHI H W,et al.Fibrinogen is associated with glucose metabolism and cardiovascular outcomes in patients with coronary artery disease［J］.Cardiovasc Diabetol,2020,19(1):36.
［2］　穆利英,吴昱,孟帅,等.纤维蛋白原与急性冠脉综合征患者冠状动脉病变严重程度的关系研究［J］.实用心脑肺血管病杂志,2020,28(2):23-26.
［3］　赵一品.非瓣膜性心房颤动患者纤维蛋白原/白蛋白比值与CHA2DS2-VASc评分的相关性研究［D］.郑州：郑州大学,2019.
［4］　PEARSON M J,MUNGOVAN S F,SMART N A.Effect of aerobic and resistance training on inflammatory markers in heart failure patients:systematic review and meta-analysis［J］.Heart Failure Rev,2018,23(2):209-223.
［5］　HSU S H,JANG M H,TORNG P L,et al.Positive association between small dense low-density lipoprotein cholesterol concentration and biomarkers of inflammation,thrombosis,and prediabetes in non-diabetic adults［J］.J Atheroscler Thromb,2019,26(7):624-635.
［6］　SOVOV Zˇ,S′TIKAROV J,KAUFMANOV J,et al.Impact of posttranslational modifications on atomistic structure of fibrinogen［J］.PLoS One,2020,15(1):e0227543.
［7］　LI T,WANG F,PENG R,et al.Sex-related differences in the association between plasma fibrinogen and non-calcified or mixed coronary atherosclerotic plaques［J］.Biol Sex Differ,2018,9(1):51.
［8］　YUCEL O，GUL I，ZARARSIZ A，et al.Association of soluble ST2 with functional capacity in outpatients with heart failure［J］.Herz，2018，43（5）：455-460.
［9］　LANDERS C T,TUNG H Y,KNIGHT J M,et al.Selective cleavage of fibrinogen by diverse proteinases initiates innate allergic and antifungal immunity through CD11b［J］.J Biol Chem,2019,294(22):8834-8847.
［10］　SHABAN A,SHAHID S U,SARWAR S.The abnormal lipid profile in obesity and coronary heart disease (CHD) in pakistani subjects［J］.Lipids Health Dis，2020,19(1):73.
［11］　GAO X Y,ZHOU B Y,ZHANG M Z,et al．Association between fibrinogen level and the severity of coronary stenosis in 418 male patients with myocardial infarction younger than 35 years old［J］.Oncotarget,2017,8(46):81361-81368．
［12］　范沛英.冠心病患者纤维蛋白原、血栓前体蛋白、高浓度脂蛋白(a)及Copeptin水平的变化及临床意义研究［J］.中国当代医药,2019,26(25):45-48.
［13］　HAN K,LU Q,ZHU W J,et al.Correlations of degree of coronary artery stenosis with blood lipid,CRP,Hcy,GGT,Scd36 and fibrinogen levels in elderly patients with coronary heart disease［J］.Eur Rev Med Pharmacol Sci,2019,23(21):9582-9589.
［14］　熊国均,黄楷森,欧荣华,等.纤维蛋白原与白蛋白比值对多支血管病变性急性心肌梗死患者PCI术后远期预后的预测价值［J］.疑难病杂志,2019,18(12):1212-1217.
［15］　HE D,JIAO Y,YU T，et al.Prognostic value of fibrinogen-to-albumin ratio in predicting 1-year clinical progression in patients with non-ST elevation acute coronary syndrome undergoing percutaneous coronary intervention［J］.Exp Ther Med，2019,18(4):2972-2978.
［16］　DEL TURCO S,BASTA G,DE CATERINA A R,et al.Different inflammatory profile in young and elderly STEMI patients undergoing primary percutaneous coronary intervention (PPCI):its influence on no-reflow and mortality［J］.Int J Cardiol,2019,290:34-39.
［17］　JIANG P,GAO Z,ZHAO W,et al.Relationship between fibrinogen levels and cardiovascular events in patients receiving percutaneous coronary intervention:a large single-center study［J］.Chin Med J,2019,132(8):914-921.
［18］　SONG J,YU T T,SUN Z J,et al.Comparison of prognostic significance between serum fibrinogen and global registry of acute coronary events score for prognosis of patients with non-ST-elevation acute coronary syndromes undergoing percutaneous coronary intervention［J］.Coron Artery Dis,2020,31(2):124-129.
［19］　WANG Y B,FU X H,GU X S,et al.Effects of intensive pitavastatin therapy on glucose control in patients with non-ST elevation acute coronary syndrome［J］.Am J Cardiovasc Dis,2017,7(4):89-96.
［20］　ZHANG L Z,XU C B,LIU J H,et al.Baseline plasma fibrinogen is associated with haemoglobin A1c and 2-year major adverse cardiovascular events following percutaneous coronary intervention in patients with acute coronary syndrome:a single-centre,prospective cohort study［J］.Cardiovasc Diabetol,2019,18(1):52.
［21］　WEYMANN A,SABASHNIKOV A,ALI-HASAN-AL-SAEGH S,et al.Predictive role of coagulation,fibrinolytic,and endothelial markers in patients with atrial fibrillation,stroke,and thromboembolism:a meta-analysis,meta-regression,and systematic review［J］.Med Sci Monit Basic Res,2017,23(9):97-140．
［22］　ERDOGAN D,UYSAL BA,AKSOY F,et al.Strict heart rate control attenuates prothrombotic state and platelet activity in patients with non-valvular permanent atrial fibrillation［J］.Clin Hemorheol Microcirc,2014,56(3):219-229.
［23］　SEMCZUK-KACZMAREK K,PLATEK A E,RYS′A,et al.CHA2DS2-VASc score and fibrinogen concentration in patients with atrial fibrillation［J］.Adv Clin Exp Med,2019,28(11):1451-1457.
［24］　OSMAN J,TAN S C,LEE P Y,et al.Sudden cardiac death (SCD)-risk stratification and prediction with molecular biomarkers［J］.J Biomed Sci,2019,26(1):39.
［25］　MITCHELL R N,ASHAR F N,JARVELIN M R,et al.Effect of sex and underlying disease on the genetic association of QT interval and sudden cardiac death［J］.J Am Heart Assoc,2019,8 (23):e013751.
［26］　赵珊,王连生.不同时间段运动对心血管事件影响的研究进展［J］.中国康复,2014,29(5):381-383.
［27］　KUNUTSOR S K,KURL S,ZACCARDI F,et al.Baseline and long-term fibrinogen levels and risk of sudden cardiac death:a new prospective study and meta-analysis［J］.Atherosclerosis,2016,245:171-180.
［28］　EMPANA J P,JOUVEN X,CANOU-POITRINE F,et al.C-reactive protein,interleukin 6,fibrinogen and risk of sudden death in european middle-aged men:the prime study［J］.Arterioscler Thromb Vasc Biol,2010,30(10):2047-2052.
［29］　韦洪弟,韦巍,农克继,等.老年性慢性心力衰竭反复发作的危险因素及其预防措施［J］.解放军预防医学杂志,2019,37(7):91-92.
［30］　黄敏江,王启东.危重症患者心力衰竭的危险因素分析［J］.中国医学创新,2019,16(21):21-24.
［31］　ME＇NDEZ-BARBERO N,GUTIE＇RREZ-MUN~OZ C,BLA~ZQUEZ-SERRA R,et al.Tumor necrosis factor-like weak inducer of apoptosis (TWEAK)/fibroblast growth factor-inducible 14 (FN14) axis in cardiovascular diseases:progress and challenges［J］.Cells,2020,9(2):405.
［32］　LUND A,GIIL L M,SLETTOM G,et al.Antibodies to receptors are associated with biomarkers of inflammation and myocardial damage in heart failure［J］.Int J Cardiol，2018,250:253-259.
［33］　MEHMOOD M.Inflammation,heart failure,and the path forward［J］.JACC Heart Fail,2020,8(2):153-154.
［34］　DE BOER R A,NAYOR M,DEFILIPPI C R,et al.Association of cardiovascular biomarkers with incident heart failure with preserved and reduced ejection fraction［J］.JAMA Cardiol,2018,3(3):215-224．
［35］　PONIKOWSKI P,VOORS A A,ANKER S D,et al.2016 esc guidelines for the diagnosis and treatment of acute and chronic heart failure:the task force for the diagnosis and treatment of acute and chronic heart failure of the european society of cardiology (ESC).Developed with the special contribution of the heart failure association (HFA) of the ESC［J］.Eur J Heart Fail,2016,18(8):891-975．
［36］　DE MEIRELLES L R,MATSUURA C,RESENDE A D E C,et al.Chronic exercise leads to antiaggregant,antioxidant and anti-inflammatory effects in heart failure patients［J］.Eur J Prev Cardiolog,2014,21(10):1225-1232.
［37］　PEARSON M J,MUNGOVAN S F,SMART N A.Effect of aerobic and resistance training on inflammatory markers in heart failure patients:systematic review and meta-analysis［J］.Heart Fail Rev,2018,23(2):209-223．
［38］　CANSECO-AVILA L M,LOPEZ-ROBLERO A,SERRANO-GUZMAN E,et al.Polymorphisms -455G/A and -148C/T and fibrinogen plasmatic level as risk markers of coronary disease and major adverse cardiovascular events［J］.Dis Markers,2019,2019:5769514.
［39］　NAJI D H,TAN C,HAN F,et al.Significant genetic association of a functional TFPI variant with circulating fibrinogen levels and coronary artery disease［J］.Mol Genet Genomics,2018,293(1):119-128.
［40］　SHARP D S,ABBOTT R D,BURCHFIEL C M,et al.Plasma fibrinogen and coronary heart disease in elderly Japanese-American men［J］.Arterioscler Thromb Vasc Biol,1996,16(2):262-268.
［41］　KAPTOGE S,DI ANGELANTONIO E,PENNELLS L A,et al.C-reactive protein,fibrinogen,and cardiovascular disease prediction［J］.N Engl J Med,2012,367(14):1310-1320.
［42］　霍晓丽,姚怀娟,潘琳琳,等.糖尿病高脂血症患者纤维蛋白原和血脂指标在诊断颈动脉狭窄的价值［J］.实用糖尿病杂志,2018,14(5):21-22.
［43］　YU E,HSU H R,HUANG C Y,et al.Inflammatory biomarkers and risk of atherosclerotic cardiovascular disease［J］.Open Med(Wars),2018,13:208-213.
［44］　DHAS Y,BANERJEE J,MISHRA N.Blood viscosity,glycemic markers and blood pressure:a study in middle-aged normotensive and hypertensive type 2 diabetics［J］.Indian J Clin Biochem,2020,35(1):102-108.

相似文献/References:

[1]王玉红,李 强,高 明,等.手术前4项凝血功能检测的临床意义[J].新乡医学院学报,2001,18(06):415.
[2]张金莲,董艳臣,齐伟,等.液体组织凝血活酶试剂在COACHROMEⅣ 仪器上的应用[J].新乡医学院学报,2003,20(02):104.
[3]张金莲,董艳臣,齐　伟,等.液体组织凝血活酶试剂在COACHROME Ⅳ仪器上的应用[J].新乡医学院学报,2003,20(02):104.
[4]徐军伟,卢　芳,钱跃磊,等.灯盏生脉胶囊联合替格瑞洛用于急性心肌梗死经皮冠状动脉介入术后的疗效及对患者凝血功能的影响[J].新乡医学院学报,2020,37(7):622.[doi:10.7683/xxyxyxb.2020.07.005]
　XU Junwei,LU Fang,QIAN Yuelei,et al.Therapeutic effect of Dengzhan Shengmai capsule combined with ticagrelor in treatment of acute myocardial infarction after percutaneous coronary intervention and its effect on coagulation function of patients[J].Journal of Xinxiang Medical University,2020,37(5):622.[doi:10.7683/xxyxyxb.2020.07.005]
[5]谭静,常方方,皇甫赟,等.外周血C-反应蛋白、血小板与淋巴细胞比值及纤维蛋白原联合检测对早期糖尿病肾病的诊断价值[J].新乡医学院学报,2023,40(8):736.[doi:10.7683/xxyxyxb.2023.08.006]
　TAN Jing,CHANG Fangfang,HUANGFU Yun,et al.Diagnostic value of combined detection of C-reactive protein,whole blood platelet to lymphocyte ratio and plasma fibrinogen in peripheral blood of patients with early diabetes nephropathy[J].Journal of Xinxiang Medical University,2023,40(5):736.[doi:10.7683/xxyxyxb.2023.08.006]

更新日期/Last Update: 2020-05-05